comprehensive
Previous article:
As demand for Covid shots wanes, Moderna seeks its next success
Next article: JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
Next article: JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
leisure time
leisure time
-
A preacher's new calling: Diversifying neuroscience research
2025-10-02 22:14 -
Listen: Wegovy in the brain & pivotal Alzheimer's data
2025-10-02 22:02 -
FDA approves RSV monoclonal antibody for infants, toddlers
2025-10-02 21:50 -
How dance can help nurses traumatized by Covid
2025-10-02 21:44 -
JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
2025-10-02 20:24 -
Physician assistants need a new name. Here's what it should be
2025-10-02 20:19